Page last updated: 2024-11-08

7-oxodehydroepiandrosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-ketodehydroepiandrosterone : A 3beta-hydroxy-Delta(5)-steroid that is dehydroepiandrosterone carrying an additional oxo group at position 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID193313
CHEBI ID183808
SCHEMBL ID600097
MeSH IDM0043740

Synonyms (40)

Synonym
AC-13409
3-hydroxy-10,13-dimethyl-2,3,4,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-7,17-dione
7-oxodehydroepiandrosterone
AKOS005146223
3beta-hydroxy-5-androstene-7,17-dione
5-androsten-3beta-ol-7,17-dione
566-19-8
7-ketoprasterone
7-oxo-dehydroepiandrosterone
CHEBI:183808
7-ketodehydroepiandrosterone
3beta-hydroxyandrost-5-ene-7,17-dione
7-oxo-dhea
7-keto-dehydroepiandrosterone
7-oxoprasterone
7-keto-dhea
7-keto
A831119
(3s,8r,9s,10r,13s,14s)-3-hydroxy-10,13-dimethyl-2,3,4,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-7,17-dione
2334ljd2e9 ,
dhea, 7-keto-
unii-2334ljd2e9
SCHEMBL600097
7-oxo-prasterone
androst-5-ene-7,17-dione, 3-hydroxy-, (3.beta.)-
7-keto-dehydroepiandrosterone [who-dd]
(3s,8r,9s,10r,13s,14s)-3-hydroxy-10,13-dimethyl-3,4,9,10,11,12,13,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-7,17(2h,8h)-dione
KPRGOTLNGIBVFL-GINZOMEDSA-N
7-oxo dhea
Q-200562
7-keto dhea
androst-5-ene-7,17-dione, 3-hydroxy-, (3b)-
mfcd00198500
3-hydroxy-10,13-dimethyl-3,4,9,10,11,12,13,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-7,17(2h,8h)-dione
DS-8228
Q4642869
AMY27580
DTXSID801024029
PD076289
(3as,3br,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthrene-1,4-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human blood serum metaboliteAny metabolite (endogenous or exogenous) found in human blood serum samples.
nutraceuticalA product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
prohormoneAny intra-glandular substance that acts as a precursor of a hormone, usually having minimal hormonal effect itself. Prohormones generally help in amplifying the effect of existing hormones.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
17-oxo steroidAny oxo steroid carrying the oxo group at position 17.
3beta-hydroxy-Delta(5)-steroidAny 3beta-hydroxy-steroid that contains a double bond between positions 5 and 6.
androstanoidAny steroid based on an androstane skeleton and its derivatives.
7-oxo steroidAny oxo steroid carrying an oxo group at position 7.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (11.11)18.2507
2000's6 (33.33)29.6817
2010's7 (38.89)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.83 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (16.67%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]